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Introduction
Treatment of microbial infections is mostly based on the use of common therapeutic antibiotics. Since the common therapeutic antibiotics are extensively used, the pathogenic microorganisms have mostly become resistant to these chemicals Furthermore, common therapeutic antibiotics are usually associated with adverse effects including hypersensitivity, immune-suppression and allergic responses. Therefore, screening of the antimicrobial activities of medicinal herbs for the treatment of infections is as natural substitutions of the current chemical antibiotics [1] [2] [3] [4] [5] [6] . Essential oils (EO) and secondary metabolites of herbs have many uses in medicine as we as food and hygiene industries [7, 8] . The herbal EO includes various health features including antioxidant and antimicrobial activities [7, 9] . Various forms of the activated oxygen, also known as reactive oxygen species (ROS), include free radicals and nonfree radical species. [10] . The ROS exert oxidative stress in human body and break its antioxidant defense mechanism; hence, the free radicals assault cell macromolecules resulting in several physiological Downloaded from nfsr.sbmu.ac.ir at 12:08 +0330 on Sunday March 15th 2020
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disorders [11] . Relatively, studies have shown that use of chemical preservatives for long terms may result in the prevalence of various cancers. Therefore, use of chemical preservatives has been decreased during the last few decades. Indeed, use of medicinal herbs as preservatives has recently been increased due to their less unwanted side effects [12, 13] . Lemon balm with the scientific name of Melissa officinalis belongs to Lamiaceae family of plants and is native to Iran, Central Asia and Europe. In many countries, M. officinalis has been cited as a mild sedative, spasmolytic and antimicrobial agent. The M. officinalis EO has been reported as an antibacterial, antifungal and antiparasitic compound [14] [15] [16] [17] . The main purpose of this study was to investigate chemical compositions and antioxidant activities of the M. officinalis EO. Another purpose of the study was to assess antimicrobial activities of the M. officinalis EO on growth of clinical and commercial bacterial strains causing infections.
Materials and Methods

Chemicals, reagents and microbial media
Chemicals such as dimethyl sulphoxide (DMSO), butylated hydroxyl toluene (BHT), β-carotene linoleic acid (ß-CL), 2,3,5-triphenyl-tetrazolium chloride (TTC) and 2,2-diphenyl-1-picrylhydrazyl (DPPH) used in this study were purchased from SigmaAldrich, USA. Bacteriological peptone broth (BDH Chemicals, UK), tryptone soy broth (TSB) and sodium chloride (East Anglia Chemicals, UK) were also purchased. All solvents used in the study included analytical grades provided by Merck, Germany. All microbial media, Mueller-Hinton agar (MHA) and Mueller-Hinton broth (MHB), were provided by Merck, Germany.
Preparation of Melissa officinalis essential oil
After verification of the plants, collected plants were dried in shade at ambient temperature to a constant weight and then powdered using laboratory grinder. The EO was extracted according to the European Pharmacopoeia protocol. Briefly, 20 gr of the powdered M. officinalis were exposed to hydrodistillation for 1.5 h using Clevenger. The EO was dried using anhydrous sodium sulfate (Na 2 SO 4 ) and then stored at 4 °C in glass vials until used in biological studies [18] . The extraction yield of M. officinalis EO was assessed based on a method by Noshad et al., 2018 [19] .
Essential oil analysis (phytochemical and chemical components)
Phytochemical analysis of the M. officinalis EO was carried out based on the qualitative methods. Briefly, phenolic (ferric chloride), flavonoids (Shinoda test), saponins (Froth test) and alkaloids (Mayer and Bosshardt) were analyzed [18, 19] . Chemical compositions of the M. officinalis EO were analyzed using gas chromatography/mass spectrometry (GC-MS) [21] . In general, 0.1 μl of the M. officinalis EO was injected into the GC-MS. Carrier helium gas was used at a flow rate of 1 ml/min and an ionization energy of 70 eV. The individual compositions were identified via analogy of their mass spectra and retention indices (RI) with those of the valid samples and those given in the literature.
Estimation of total phenolic content (TPC)
The Folin-Ciocalteu method was used using TPC. Results were presented as mg of gallic acid (GA)/g of the dried M. officinalis EO [22] .
Antioxidant potential
The antioxidant potential of the EO was estimated using 2,2-diphenyl-1-picrylhydrazyl (DPPH) (SigmaAldrich, USA) protocol described by Alizadeh Behbahani and Imani Fooladi in 2018 [23] and Alizadeh Behbahani et al. in 2017 [24] . The radical scavenging activity percentage of DPPH was computed using the following equation (1):
Scavenging activity (%) = (Abs control -Abs sample / Abs control) ×100
Concentration of the M. officinalis EO that inhibited 50% of the DPPH radicals was reported as IC 50 value. Methods of Ozturk et al., (2011) [25] and Noshad et al., (2018) [19] were used for ß-carotenelinoleic acid assay (ß-CL). The average inhibition rate was calculated using the following equation (2) [26] .
Suspension preparation
All bacteria were cultivated on MHA under aerobic conditions for 24 h at 37
• C. Freshly cultured commercial strain and clinically isolated strain colonies were suspended in 10 ml of normal saline. Then, bacterial concentrations were adjusted to 1.5 × 10 8 CFU (colony forming units)/ml based on 0.5
McFarland [27] .
Antimicrobial activity assay
Disc diffusion agar (DDA): Antimicrobial activity of the EO was assessed using DDA method [28] . In this method, 0.1 ml of the incubated bacterial (either clinical or commercial) suspension was spread on MHA plates. Concentrations of 0.5, 1, 2, 4 and 8 mg/ml of the EO were prepared in dimethyl sulfoxide (DMSO) solvent. These were sterilized using 0.22-μm syringe microfilters. A paper disc with 6.2 mm in diameter (Padtanteb, Iran) was infused with 20 μl of the M. officinalis EO and placed on inoculated MHA plates. The culture media containing either clinical or commercial bacterial strain were incubated at 37 °C for 24 h. Finally, IZD (mm) around the disks was measured using ruler and recorded [13, 21] . Well diffusion agar (WDA): Antimicrobial activity of the EO was assessed using WDA method [29] . In this method, 5 wells were created on the surface of MHA plates using of Pasteur pipettes. A 0.1 ml of the incubated bacterial (either clinical and or commercial) suspension was spread on the culture media. Concentrations of 0.5, 1, 2, 4 and 8 mg/ml of the EO were prepared. Then, 20 μl of each concentration was poured into a well. A well was left as blank. After incubation for 24 h at 37 °C, plates were studied for IZD [30] . [19] .
Minimum bactericidal concentration (MBC):
The MBC was assessed using pour plate method [38] . Briefly, 100 µl of the solution from the wells free of red color (the MIC test) were cultured on MHA plates. The first concentration with bacterial growth on MHA was reported as MBC [19, 29] .
Statistical analysis
All experiments were carried out in triplicate. The SPSS software (IBM Analytics, USA) was used to analyze data. Data were considered as significant when P ≤ 0.05.
Results
Chemical composition, phytochemical analysis and antioxidant potential
Analysis of the M. officinalis EO extraction showed that 0.1 ml of the EO was obtained from 20 g of the M. officinalis with an extraction yield of 0.5% (v/w). Results of the EO composition analysis by GC-MS showed that the total composition constituted nearly 96.7% of the EO. Geranyl acetate with 27.9% was the major compound of the M. officinalis EO (Table 1) . Results demonstrated that the highlighted bacteria were significantly different (P ≤ 0.05) in susceptibility to various concentrations of the M. officinalis EO using DDA method. Pairwise comparison of the effects of M. officinalis EO concentrations on the bacteria (commercial and clinical strains) showed no significant differences. As the concentration increased, the IZD increased too. However, as shown in Table 3 , no significant differences (P ≤ 0.05) were seen between the concentrations of 4 and 8 mg/ml in E. coli and S. pyogenes (clinical strains). [15] demonstrated that the yield of M. officinalis EO included 0.97% (v/w). Pouyanfar et al. (2018) [17] reported that the average M. officinalis EO yield included 0.13-0.35% (w/w). During the growth cycles, the environmental agents such as amount of existing water are very important in yield of dried materials and EOs [17, 39] [15] reported that the major compositions in 13 EOs included limonene-10-ol, geraniol and caryophyllene oxide. These were reported from various countries previously. Chung et al. (2010) [14] showed 40 compositions in EO of the Melissa officinalis leaves. These majorly included monoterpene hydrocarbons, sesquiterpene hydrocarbons and oxygenated monoterpenes. In 2014, Uyanik and Gurbuz [42] demonstrated that citral, caryophyllene oxide and zcitral (in leaves and flowers), caryophyllene oxide, citral and β-caryophyllene (in whole plant) were dominant within the components. Bozovic et al. (2018) [43] reported cis-caryophyllene and its oxide form as the major EO constituents; similar to reports from the current study. Alizadeh showed that the chemical compounds of the EO varied depending upon the herbal variety, growth stage, and collection time and the climatic condition [20] . Previously, Mimica-Dukic et al. (2004) [40] showed thattheM. officinalis EO exhibited a very strong free radical scavenging capacity, reducing the DPPH radical formation (IC 50 = 7.58 µg/ml) and OH radical generation (IC 50 = 1.74 µg/ml) in a dose-dependent manner. Researches have demonstrated a direct relationship between the total phenolic content and the antioxidant potential [20, 29] .
Antimicrobial activity
Many herb EOs owe their ability to the presence of substances such as alkaloids, tannins, glycosides, flavones, anthraquinones, flavonoids, terpenes, anthocyanins, phenolics and aldehydes. These substances are generally found in multiple parts of the herbs, including leaves, roots, shoots, blossoms, flowers and barks. Many herbs have thus become the origins of major drugs and the pharmaceutical industries have become interested in these herbs as sources of bioactive factors [44] [45] [46] . Results of this study plainly revealed that the M. officinalis EO antibacterial activities on the growth of clinical and commercial strains causing infections. The effectiveness of the active components in herb EOs results in visible IZD surrounding the antimicrobial paper disks. However, some herbal EOs were unable to exhibit antimicrobial activity on clinical and commercial bacterial strains causing infections. The IZD of the M. officinalis EO varied from 10.60 mm at 8 mg/ml concentrations for P. aeruginosa to 14.40 mm at 8 mg/ml concentrations for S. pyogenes. In general, resistance profile of the clinical and commercial strains causing infections was as follows: P. aeruginosa > E. coli > S. epidermidis > S. pyogenes. According to studies, gram-negative bacteria are more resistant to the EO than gram-positive bacteria due to the external cell walls [13, 19, 20] . Results showed that MBC of the M. officinalis EO was seen at higher concentrations than MIC. Therefore, this suggested that the antibacterial substances in the EO were bacteriostatic at lower and bactericidal at higher concentrations. In 2004, Mimica-Dukic et al. [40] [19] , Alizadeh Behbahani and Imani Fooladi (2018) [23] and Alizadeh [21, 28] . In these studies, gramnegative bacteria were more resistant to EOs than gram-positive bacteria; as shown by the findings of the present study.
Conclusions
In this study, M. officinalis EO was extracted using Clevenger and hydro distillation technique. A GC-MS analysis of M. officinalis EO detected 22 compounds, representing 96.7% of the total oil composition. Major composition of the M. officinalis EO included geranyl acetate (27.9 %), citral (14.2%), Z-citral (9.8%) citronellal (8.4%) and citronellol (7.6%). Results showed that the smallest IZD on different M. officinalis EO concentrations on P. aeruginosa. Moreover, results demonstrated that the M. officinalis EO included greater inhibitory effects on commercial strains causing infections, compared to clinical strains. The M. officinalis EO included the greatest effects on gram-positive bacteria. Normally, M. officinalis EO is rich in phenolic compounds and hence an impressive free radical scavenger. Further studies are necessary to investigate potential toxicities of the extracts from M. officinalis EO due to the human safety.
